{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:55:54Z","timestamp":1782773754404,"version":"3.54.5"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00467-016-3475-5","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T14:27:37Z","timestamp":1473085657000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pathogenesis and treatment of ANCA-associated vasculitis\u2014a role for complement"],"prefix":"10.1007","volume":"33","author":[{"given":"Damien","family":"Noone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4168-3277","authenticated-orcid":false,"given":"Christoph","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"key":"3475_CR1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/BOR.0000000000000013","volume":"26","author":"M Twilt","year":"2014","unstructured":"Twilt M, Benseler S (2014) Childhood antineutrophil cytoplasmic antibodies associated vasculitides. Curr Opin Rheumatol 26:50\u201355","journal-title":"Curr Opin Rheumatol"},{"key":"3475_CR2","first-page":"i60","volume":"30","author":"K Westman","year":"2015","unstructured":"Westman K, Flossmann O, Gregorini G (2015) The long-term outcomes of systemic vasculitis. Nephrol Dial Transplant 30:i60\u2013i66","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3476(05)83482-1","volume":"122","author":"M Rottem","year":"1993","unstructured":"Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, Hoffman GS (1993) Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122:26\u201331","journal-title":"J Pediatr"},{"key":"3475_CR4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1546-0096-9-12","volume":"9","author":"N Arulkumaran","year":"2011","unstructured":"Arulkumaran N, Jawad S, Smith SW, Harper L, Brogan P, Pusey CD, Salama AD (2011) Long-term outcome of paediatric patients with ANCA vasculitis. Pediatr Rheumatol Online J 9:12","journal-title":"Pediatr Rheumatol Online J"},{"key":"3475_CR5","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.01210214","volume":"9","author":"DG Noone","year":"2014","unstructured":"Noone DG, Twilt M, Hayes WN, Thorner PS, Benseler S, Laxer RM, Parekh RS, Hebert D (2014) The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood. Clin J Am Soc Nephrol 9:1684\u20131691","journal-title":"Clin J Am Soc Nephrol"},{"key":"3475_CR6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.22774","volume":"57","author":"JD Akikusa","year":"2007","unstructured":"Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED (2007) Clinical features and outcome of pediatric Wegener\u2019s granulomatosis. Arthritis Rheum 57:837\u2013844","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"3475_CR7","first-page":"i104","volume":"30","author":"AS Sacri","year":"2015","unstructured":"Sacri AS, Chambaraud T, Ranchin B, Florkin B, See H, Decramer S, Flodrops H, Ulinski T, Allain-Launay E, Boyer O, Dunand O, Fischbach M, Hachulla E, Pietrement C, Le Pogamp P, Stephan JL, Belot A, Nivet H, Nobili F, Guillevin L, Quartier P, Deschenes G, Salomon R, Essig M, Harambat J (2015) Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study. Nephrol Dial Transplant 30[Suppl 1]:i104\u2013i112","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798\u2013806","journal-title":"Ann Rheum Dis"},{"key":"3475_CR9","first-page":"i94","volume":"30","author":"D Eleftheriou","year":"2015","unstructured":"Eleftheriou D, Batu ED, Ozen S, Brogan PA (2015) Vasculitis in children. Nephrol Dial Transplant 30:i94\u2013i103","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR10","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.24876","volume":"60","author":"DA Cabral","year":"2009","unstructured":"Cabral DA, Uribe AG, Benseler S, O\u2019Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, Dewitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D, Woodward A, ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network (2009) Classification, presentation, and initial treatment of Wegener\u2019s granulomatosis in childhood. Arthritis Rheum 60:3413\u20133424","journal-title":"Arthritis Rheum"},{"key":"3475_CR11","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00467-012-2198-5","volume":"27","author":"E Siomou","year":"2012","unstructured":"Siomou E, Tramma D, Bowen C, Milford DV (2012) ANCA-associated glomerulonephritis\/systemic vasculitis in childhood: clinical features-outcome. Pediatr Nephrol 27:1911\u20131920","journal-title":"Pediatr Nephrol"},{"key":"3475_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/art.39729","author":"DA Cabral","year":"2016","unstructured":"Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins G, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik M, Lawson E, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O\u2019Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater H, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS, ARChiVe Investigators Network within the PedVas initiative (2016) Comparing presenting clinical features of 48 children with microscopic polyangiitis (MPA) against 183 having granulomatosis with polyangiitis (GPA). An ARChiVe study. Arthritis Rheumatol. doi: 10.1002\/art.39729","journal-title":"Arthritis Rheumatol"},{"key":"3475_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semarthrit.2008.05.004","volume":"39","author":"J Zwerina","year":"2009","unstructured":"Zwerina J, Eger G, Englbrecht M, Manger B, Schett G (2009) Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. Semin Arthritis Rheum 39:108\u2013115","journal-title":"Semin Arthritis Rheum"},{"key":"3475_CR14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","volume":"285","author":"DJ Davies","year":"1982","unstructured":"Davies DJ, Moran JE, Niall JF, Ryan GB (1982) Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 285:606","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3475_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","volume":"111","author":"J Savige","year":"1999","unstructured":"Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A (1999) International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111:507\u2013513","journal-title":"Am J Clin Pathol"},{"key":"3475_CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.autrev.2012.08.008","volume":"12","author":"A Radice","year":"2013","unstructured":"Radice A, Bianchi L, Sinico RA (2013) Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 12:487\u2013495","journal-title":"Autoimmun Rev"},{"key":"3475_CR17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10067-010-1424-4","volume":"29","author":"B Bonaci-Nikolic","year":"2010","unstructured":"Bonaci-Nikolic B, Andrejevic S, Pavlovic M, Dimcic Z, Ivanovic B, Nikolic M (2010) Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge. Clin Rheumatol 29:893\u2013904","journal-title":"Clin Rheumatol"},{"key":"3475_CR18","doi-asserted-by":"crossref","unstructured":"Sugiyama H, Sahara M, Imai Y, Ono M, Okamoto K, Kikuchi K, Nagai R (2009) Infective endocarditis by Bartonella quintana masquerading as antineutrophil cytoplasmic antibody-associated small vessel vasculitis. Cardiology 114:208\u2013211","DOI":"10.1159\/000228645"},{"key":"3475_CR19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hruskova Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesar V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367:214\u2013223","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"3475_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.2011.04362.x","volume":"164","author":"CO Savage","year":"2011","unstructured":"Savage CO (2011) Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Clin Exp Immunol 164[Suppl 1]:23\u201326","journal-title":"Clin Exp Immunol"},{"key":"3475_CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BOR.0b013e32834bde57","volume":"24","author":"MM Timmeren van","year":"2012","unstructured":"van Timmeren MM, Heeringa P (2012) Pathogenesis of ANCA-associated vasculitis: recent insights from animal models. Curr Opin Rheumatol 24:8\u201314","journal-title":"Curr Opin Rheumatol"},{"key":"3475_CR22","first-page":"195","volume":"18","author":"CG Kallenberg","year":"2014","unstructured":"Kallenberg CG (2014) Advances in pathogenesis and treatment of ANCA-associated vasculitis. Discov Med 18:195\u2013201","journal-title":"Discov Med"},{"key":"3475_CR23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00281-014-0431-y","volume":"36","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ (2014) B cell-mediated pathogenesis of ANCA-mediated vasculitis. Semin Immunopathol 36:327\u2013338","journal-title":"Semin Immunopathol"},{"key":"3475_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10:463\u2013473","journal-title":"Nat Rev Rheumatol"},{"key":"3475_CR25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","volume":"14","author":"R Kain","year":"2008","unstructured":"Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, Davidovits A, Raab I, Jahn R, Ashour O, Spitzauer S, Sunder-Plassmann G, Fukuda M, Klemm P, Rees AJ, Kerjaschki D (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14:1088\u20131096","journal-title":"Nat Med"},{"key":"3475_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","volume":"10","author":"WF Pendergraft 3rd","year":"2004","unstructured":"Pendergraft WF 3rd, Preston GA, Shah RR, Tropsha A, Carter CW Jr, Jennette JC, Falk RJ (2004) Autoimmunity is triggered by cPR-3(105\u2013201), a protein complementary to human autoantigen proteinase-3. Nat Med 10:72\u201379","journal-title":"Nat Med"},{"key":"3475_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","volume":"8","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Hu P, Xiao H (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8:139\u2013160","journal-title":"Annu Rev Pathol"},{"key":"3475_CR28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2008.309","volume":"74","author":"J Yang","year":"2008","unstructured":"Yang J, Bautz DJ, Lionaki S, Hogan SL, Chin H, Tisch RM, Schmitz JL, Pressler BM, Jennette JC, Falk RJ, Preston GA (2008) ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int 74:1159\u20131169","journal-title":"Kidney Int"},{"key":"3475_CR29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.autrev.2016.03.007","volume":"15","author":"PA Jarrot","year":"2016","unstructured":"Jarrot PA, Kaplanski G (2016) Pathogenesis of ANCA-associated vasculitis: an update. Autoimmun Rev 15:704\u2013713","journal-title":"Autoimmun Rev"},{"key":"3475_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10875-006-9051-1","volume":"27","author":"DA Culton","year":"2007","unstructured":"Culton DA, Nicholas MW, Bunch DO, Zhen QL, Kepler TB, Dooley MA, Mohan C, Nachman PH, Clarke SH (2007) Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 27:53\u201368","journal-title":"J Clin Immunol"},{"key":"3475_CR31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2567.2009.03213.x","volume":"130","author":"MD Morgan","year":"2010","unstructured":"Morgan MD, Day CJ, Piper KP, Khan N, Harper L, Moss PA, Savage CO (2010) Patients with Wegener\u2019s granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology 130:64\u201373","journal-title":"Immunology"},{"key":"3475_CR32","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/ndt\/gfp783","volume":"25","author":"E Nogueira","year":"2010","unstructured":"Nogueira E, Hamour S, Sawant D, Henderson S, Mansfield N, Chavele KM, Pusey CD, Salama AD (2010) Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 25:2209\u20132217","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1681\/ASN.2009070763","volume":"21","author":"PY Gan","year":"2010","unstructured":"Gan PY, Steinmetz OM, Tan DS, O\u2019Sullivan KM, Ooi JD, Iwakura Y, Kitching AR, Holdsworth SR (2010) Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol 21:925\u2013931","journal-title":"J Am Soc Nephrol"},{"key":"3475_CR34","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/annrheumdis-2012-202986","volume":"72","author":"B Wilde","year":"2013","unstructured":"Wilde B, Thewissen M, Damoiseaux J, Knippenberg S, Hilhorst M, van Paassen P, Witzke O, Cohen Tervaert JW (2013) Regulatory B cells in ANCA-associated vasculitis. Ann Rheum Dis 72:1416\u20131419","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"3475_CR35","first-page":"i46","volume":"30","author":"U Schonermarck","year":"2015","unstructured":"Schonermarck U, Csernok E, Gross WL (2015) Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014. Nephrol Dial Transplant 30[Suppl 1]:i46\u201352","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15:623\u2013625","journal-title":"Nat Med"},{"key":"3475_CR37","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2012-03-416156","volume":"120","author":"S Sangaletti","year":"2012","unstructured":"Sangaletti S, Tripodo C, Chiodoni C, Guarnotta C, Cappetti B, Casalini P, Piconese S, Parenza M, Guiducci C, Vitali C, Colombo MP (2012) Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 120:3007\u20133018","journal-title":"Blood"},{"key":"3475_CR38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10157-012-0738-8","volume":"17","author":"D Nakazawa","year":"2013","unstructured":"Nakazawa D, Tomaru U, Ishizu A (2013) Possible implication of disordered neutrophil extracellular traps in the pathogenesis of MPO-ANCA-associated vasculitis. Clin Exp Nephrol 17:631\u2013633","journal-title":"Clin Exp Nephrol"},{"key":"3475_CR39","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1681\/ASN.2013060606","volume":"25","author":"D Nakazawa","year":"2014","unstructured":"Nakazawa D, Shida H, Tomaru U, Yoshida M, Nishio S, Atsumi T, Ishizu A (2014) Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J Am Soc Nephrol 25:990\u2013997","journal-title":"J Am Soc Nephrol"},{"key":"3475_CR40","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","volume":"188","author":"J Leffler","year":"2012","unstructured":"Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, Bengtsson AA, Blom AM (2012) Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 188:3522\u20133531","journal-title":"J Immunol"},{"key":"3475_CR41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cei.12654","volume":"181","author":"H Wang","year":"2015","unstructured":"Wang H, Wang C, Zhao MH, Chen M (2015) Neutrophil extracellular traps can activate alternative complement pathways. Clin Exp Immunol 181:518\u2013527","journal-title":"Clin Exp Immunol"},{"key":"3475_CR42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00005792-197311000-00002","volume":"52","author":"AS Fauci","year":"1973","unstructured":"Fauci AS, Wolff SM (1973) Wegener\u2019s granulomatosis: studies in eighteen patients and a review of the literature. Medicine 52:535\u2013561","journal-title":"Medicine"},{"key":"3475_CR43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-67-2-393","volume":"67","author":"D Hollander","year":"1967","unstructured":"Hollander D, Manning RT (1967) The use of alkylating agents in the treatment of Wegener\u2019s granulomatosis. Ann Intern Med 67:393\u2013398","journal-title":"Ann Intern Med"},{"key":"3475_CR44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488\u2013498","journal-title":"Ann Intern Med"},{"key":"3475_CR45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C, European Vasculitis Study Group (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36\u201344","journal-title":"N Engl J Med"},{"key":"3475_CR46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(77)91079-0","volume":"1","author":"CM Lockwood","year":"1977","unstructured":"Lockwood CM, Pinching AJ, Sweny P, Rees AJ, Pussell B, Uff J, Peters DK (1977) Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet 1:63\u201367","journal-title":"Lancet"},{"key":"3475_CR47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","volume":"40","author":"CD Pusey","year":"1991","unstructured":"Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM (1991) Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 40:757\u2013763","journal-title":"Kidney Int"},{"key":"3475_CR48","first-page":"i146","volume":"30","author":"WM Szpirt","year":"2015","unstructured":"Szpirt WM (2015) Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis\u2014a 25-year perspective. Nephrol Dial Transplant 30:i146\u2013i149","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR49","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DR Jayne","year":"2007","unstructured":"Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD, European Vasculitis Study Group (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"3475_CR50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","volume":"57","author":"M Walsh","year":"2011","unstructured":"Walsh M, Catapano F, Szpirt W, Thorlund K, Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C, Jayne D (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 57:566\u2013574","journal-title":"Am J Kidney Dis"},{"key":"3475_CR51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","volume":"14","author":"M Walsh","year":"2013","unstructured":"Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, De Zoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D, Investigators PEXIVAS (2013) Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials 14:73","journal-title":"Trials"},{"key":"3475_CR52","doi-asserted-by":"crossref","first-page":"i164","DOI":"10.1093\/ndt\/gfv231","volume":"30","author":"L Wong","year":"2015","unstructured":"Wong L, Harper L, Little MA (2015) Getting the balance right: adverse events of therapy in anti-neutrophil cytoplasm antibody vasculitis. Nephrol Dial Transplant 30:i164\u2013i170","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11926-012-0238-6","volume":"14","author":"M Twilt","year":"2012","unstructured":"Twilt M, Benseler S, Cabral D (2012) Granulomatosis with polyangiitis in childhood. Curr Rheumatol Rep 14:107\u2013115","journal-title":"Curr Rheumatol Rep"},{"key":"3475_CR54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40697-015-0078-1","volume":"2","author":"L McGeoch","year":"2015","unstructured":"McGeoch L, Twilt M, Famorca L, Bakowsky V, Barra L, Benseler S, Cabral DA, Carette S, Cox GP, Dhindsa N, Dipchand C, Fifi-Mah A, Goulet M, Khalidi N, Khraishi MM, Liang P, Milman N, Pineau CA, Reich H, Samadi N, Shojania K, Taylor-Gjevre R, Towheed TE, Trudeau J, Walsh M, Yacyshyn E, Pagnoux C, Canadian Vasculitis research network (CanVasc) (2015) CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides\u2014Executive summary. Can J Kidney Health Dis 2:43","journal-title":"Can J Kidney Health Dis"},{"key":"3475_CR55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3899\/jrheum.150376","volume":"43","author":"L McGeoch","year":"2016","unstructured":"McGeoch L, Twilt M, Famorca L, Bakowsky V, Barra L, Benseler SM, Cabral DA, Carette S, Cox GP, Dhindsa N, Dipchand CS, Fifi-Mah A, Goulet M, Khalidi N, Khraishi MM, Liang P, Milman N, Pineau CA, Reich HN, Samadi N, Shojania K, Taylor-Gjevre R, Towheed TE, Trudeau J, Walsh M, Yacyshyn E, Pagnoux C, Canadian Vasculitis Research Network (2016) CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides. J Rheumatol 43:97\u2013120","journal-title":"J Rheumatol"},{"key":"3475_CR56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310\u2013317","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"3475_CR57","first-page":"139","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Working Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Working Group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int 2[Suppl 2]:139\u2013274","journal-title":"Kidney Int"},{"key":"3475_CR58","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, D\u2019Cruz D, Harper L, Jayne D, Luqmani R, Mills J, Mooney J, Venning M, Watts RA, BSR and BHPR Standards, Guidelines and Audit Working Group (2014) BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology 53:2306\u20132309","journal-title":"Rheumatology"},{"key":"3475_CR59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh D, Walsh M, Westman K, Jayne DR, European Vasculitis Study Group (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211\u2013220","journal-title":"N Engl J Med"},{"key":"3475_CR60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"3475_CR61","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","volume":"74","author":"RB Jones","year":"2015","unstructured":"Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR, European Vasculitis Society (EUVAS) (2015) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Ann Rheum Dis 74:1178\u20131182","journal-title":"Ann Rheum Dis"},{"key":"3475_CR62","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaitre O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quemeneur T, Blanchard-Delaunay C, Godmer P, Puechal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, French Vasculitis Study Group (2014) Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 371:1771\u20131780","journal-title":"N Engl J Med"},{"key":"3475_CR63","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2215\/CJN.02181205","volume":"1","author":"D Huugen","year":"2006","unstructured":"Huugen D, Tervaert JW, Heeringa P (2006) TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations. Clin J Am Soc Nephrol 1:1100\u20131107","journal-title":"Clin J Am Soc Nephrol"},{"key":"3475_CR64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2005060616","volume":"17","author":"MA Little","year":"2006","unstructured":"Little MA, Bhangal G, Smyth CL, Nakada MT, Cook HT, Nourshargh S, Pusey CD (2006) Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis. J Am Soc Nephrol 17:160\u2013169","journal-title":"J Am Soc Nephrol"},{"key":"3475_CR65","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","volume":"41","author":"P Bartolucci","year":"2002","unstructured":"Bartolucci P, Ramanoelina J, Cohen P, Mahr A, Godmer P, Le Hello C, Guillevin L (2002) Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology 41:1126\u20131132","journal-title":"Rheumatology"},{"key":"3475_CR66","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/41.11.1303","volume":"41","author":"P Lamprecht","year":"2002","unstructured":"Lamprecht P, Voswinkel J, Lilienthal T, Nolle B, Heller M, Gross WL, Gause A (2002) Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener\u2019s granulomatosis. Rheumatology 41:1303\u20131307","journal-title":"Rheumatology"},{"key":"3475_CR67","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","volume":"109","author":"AD Booth","year":"2004","unstructured":"Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB (2004) Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation 109:1718\u20131723","journal-title":"Circulation"},{"key":"3475_CR68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","unstructured":"Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group (2005) Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N Engl J Med 352:351\u2013361","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"3475_CR69","doi-asserted-by":"crossref","first-page":"iv31","DOI":"10.1136\/ard.2005.042416","volume":"64","author":"C Mukhtyar","year":"2005","unstructured":"Mukhtyar C, Luqmani R (2005) Current state of tumour necrosis factor {alpha} blockade in Wegener\u2019s granulomatosis. Ann Rheum Dis 64[Suppl 4]:iv31\u201336","journal-title":"Ann Rheum Dis"},{"key":"3475_CR70","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11926-012-0290-2","volume":"14","author":"F Silva","year":"2012","unstructured":"Silva F, Cisternas M, Specks U (2012) TNF-alpha blocker therapy and solid malignancy risk in ANCA-associated vasculitis. Curr Rheumatol Rep 14:501\u2013508","journal-title":"Curr Rheumatol Rep"},{"key":"3475_CR71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2015.02.002","volume":"45","author":"A Berti","year":"2015","unstructured":"Berti A, Cavalli G, Campochiaro C, Guglielmi B, Baldissera E, Cappio S, Sabbadini MG, Doglioni C, Dagna L (2015) Interleukin-6 in ANCA-associated vasculitis: rationale for successful treatment with tocilizumab. Semin Arthritis Rheum 45:48\u201354","journal-title":"Semin Arthritis Rheum"},{"key":"3475_CR72","first-page":"921","volume":"135","author":"JC Jennette","year":"1989","unstructured":"Jennette JC, Wilkman AS, Falk RJ (1989) Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135:921\u2013930","journal-title":"Am J Pathol"},{"key":"3475_CR73","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10875-008-9268-2","volume":"29","author":"GQ Xing","year":"2009","unstructured":"Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, Zheng XEJ, Kallenberg CG, Zhao MH (2009) Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 29:282\u2013291","journal-title":"J Clin Immunol"},{"key":"3475_CR74","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","volume":"170","author":"H Xiao","year":"2007","unstructured":"Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC (2007) Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170:52\u201364","journal-title":"Am J Pathol"},{"key":"3475_CR75","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.4049\/jimmunol.158.9.4444","volume":"158","author":"U Wirthmueller","year":"1997","unstructured":"Wirthmueller U, Dewald B, Thelen M, Schafer MK, Stover C, Whaley K, North J, Eggleton P, Reid KB, Schwaeble WJ (1997) Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 158:4444\u20134451","journal-title":"J Immunol"},{"key":"3475_CR76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0171-2985(96)80050-7","volume":"195","author":"W Vogt","year":"1996","unstructured":"Vogt W (1996) Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 195:334\u2013346","journal-title":"Immunobiology"},{"key":"3475_CR77","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.ki.5002103","volume":"71","author":"D Huugen","year":"2007","unstructured":"Huugen D, van Esch A, Xiao H, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P (2007) Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 71:646\u2013654","journal-title":"Kidney Int"},{"key":"3475_CR78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","volume":"20","author":"A Schreiber","year":"2009","unstructured":"Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R (2009) C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 20:289\u2013298","journal-title":"J Am Soc Nephrol"},{"key":"3475_CR79","volume":"7","author":"J Hao","year":"2012","unstructured":"Hao J, Meng LQ, Xu PC, Chen M, Zhao MH (2012) p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation. PLoS One 7, e38317","journal-title":"PLoS One"},{"key":"3475_CR80","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2012.10.041","volume":"54","author":"J Hao","year":"2013","unstructured":"Hao J, Chen M, Zhao MH (2013) Involvement of protein kinase C in C5a-primed neutrophils for ANCA-mediated activation. Mol Immunol 54:68\u201373","journal-title":"Mol Immunol"},{"key":"3475_CR81","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ndt\/18.3.524","volume":"18","author":"I Neumann","year":"2003","unstructured":"Neumann I, Regele H, Kain R, Birck R, Meisl FT (2003) Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant 18:524\u2013531","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR82","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000420610","volume":"94","author":"P Ronco","year":"1991","unstructured":"Ronco P, Mougenot B, Bindi P, Vanhille P, Mignon F (1991) Clinicohistological features and long-term outcome of Wegener\u2019s granulomatosis. Contrib Nephrol 94:47\u201357","journal-title":"Contrib Nephrol"},{"key":"3475_CR83","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/j.1523-1755.2004.00632.x","volume":"65","author":"M Haas","year":"2004","unstructured":"Haas M, Eustace JA (2004) Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 65:2145\u20132152","journal-title":"Kidney Int"},{"key":"3475_CR84","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar3873","volume":"14","author":"J Yuan","year":"2012","unstructured":"Yuan J, Gou SJ, Huang J, Hao J, Chen M, Zhao MH (2012) C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Arthritis Res Ther 14:R140","journal-title":"Arthritis Res Ther"},{"key":"3475_CR85","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1681\/ASN.2010080858","volume":"23","author":"S Roux Le","year":"2012","unstructured":"Le Roux S, Pepper RJ, Dufay A, Neel M, Meffray E, Lamande N, Rimbert M, Josien R, Hamidou M, Hourmant M, Cook HT, Charreau B, Larger E, Salama AD, Fakhouri F (2012) Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 23:155\u2013164","journal-title":"J Am Soc Nephrol"},{"key":"3475_CR86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","volume":"83","author":"SJ Gou","year":"2013","unstructured":"Gou SJ, Yuan J, Chen M, Yu F, Zhao MH (2013) Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 83:129\u2013137","journal-title":"Kidney Int"},{"key":"3475_CR87","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13075-015-0656-8","volume":"17","author":"SF Chen","year":"2015","unstructured":"Chen SF, Wang FM, Li ZY, Yu F, Zhao MH, Chen M (2015) Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis. Arthritis Res Ther 17:129","journal-title":"Arthritis Res Ther"},{"key":"3475_CR88","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv288","author":"M Hilhorst","year":"2015","unstructured":"Hilhorst M, van Paassen P, van Rie H, Bijnens N, Heerings-Rewinkel P, van Breda VP, Cohen Tervaert JW, Limburg Renal R (2015) Complement in ANCA-associated glomerulonephritis. Nephrol Dial Transplant. doi: 10.1093\/ndt\/gfv288","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR89","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.2215\/CJN.00120115","volume":"10","author":"L Manenti","year":"2015","unstructured":"Manenti L, Vaglio A, Gnappi E, Maggiore U, Allegri L, Allinovi M, Urban ML, Delsante M, Galetti M, Nicastro M, Pilato FP, Buzio C (2015) Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis. Clin J Am Soc Nephrol 10:2143\u20132151","journal-title":"Clin J Am Soc Nephrol"},{"key":"3475_CR90","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2013020143","volume":"25","author":"H Xiao","year":"2014","unstructured":"Xiao H, Dairaghi DJ, Powers JP, Ertl LS, Baumgart T, Wang Y, Seitz LC, Penfold ME, Gan L, Hu P, Lu B, Gerard NP, Gerard C, Schall TJ, Jaen JC, Falk RJ, Jennette JC (2014) C5a receptor (CD88) blockade protects against MPO-ANCA GN. J Am Soc Nephrol 25:225\u2013231","journal-title":"J Am Soc Nephrol"},{"key":"3475_CR91","first-page":"ii419","volume":"27","author":"P Bekker","year":"2012","unstructured":"Bekker P, Potarca A, Dairaghi D, Miao S, Powers JP, Jaen JC, Schall TJ (2012) Oral C5A receptor antagonist CCX168 in a phase 2 clinical trial in anca-associated renal vasculitis. Nephrol Dial Transplant 27:ii419\u2013ii420","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR92","first-page":"2032","volume":"62","author":"DJ Dairaghi","year":"2010","unstructured":"Dairaghi DJ, Jaen JC, Deshayes K, Johnson DA, Leleti MR, Miao S, Powers JP (2010) Phase 1 clinical safety, pharmacokinetic and pharmacodynamic evaluation of the novel C5aR antagonist CCX168, a potential therapeutic for ANCA-vasculitis. Arthritis Rheum 62:2032","journal-title":"Arthritis Rheum"},{"key":"3475_CR93","first-page":"ii401","volume":"27","author":"D Dairaghi","year":"2012","unstructured":"Dairaghi D, Johnson D, Leleti M, Miao S, Xiao H, Jennette JC, Powers JP, Seitz L, Wang Y, Jaen JC, Schall TJ, Bekker P (2012) Clinical dose selection of the C5A receptor antagonist ccx168 for the phase 2 ANCA-associated renal vasculitis clinical trial (the clear trial). Nephrol Dial Transplant 27:ii401\u2013ii402","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR94","doi-asserted-by":"crossref","first-page":"iii27","DOI":"10.1093\/ndt\/gfu120","volume":"29","author":"DRW Jayne","year":"2014","unstructured":"Jayne DRW, Bruchfeld A, Schaier M, Ciechanowski K, Harper L, Jadoul M, Segelmark M, Selga D, Szombati I, Venning M, Hamilton P, Hugo C, Van Daele PLA, Viklicky O, Potarca A, Schall TJ, Bekker P (2014) Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis. Nephrol Dial Transplant 29:iii27","journal-title":"Nephrol Dial Transplant"},{"key":"3475_CR95","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/annrheumdis-2014-eular.3728","volume":"73","author":"DR Jayne","year":"2014","unstructured":"Jayne DR, Bruchfeld A, Schaier M, Ciechanowski K, Harper L, Jadoul M, Segelmark M, Selga D, Szombati I, Venning M, Hugo C, Van Daele PL, Viklicky O, Potarca A, Schall TJ, Bekker P (2014) OP0227 Oral C5A receptor antagonist CCX168 phase 2 clinical trial in ANCA-associated renal vasculitis. Ann Rheum Dis 73:148","journal-title":"Ann Rheum Dis"},{"key":"3475_CR96","first-page":"S820","volume":"66","author":"P Bekker","year":"2014","unstructured":"Bekker P, Jayne D, Bruchfeld A, Schaier M, Ciechanowski K, Harper L, Jadoul M, Segelmark M, Selga D, Szombati I, Venning M, Hugo C, Van Daele PL, Viklicky O, Potarca A, Schall TJ (2014) CCX168, an orally administered C5aR inhibitor for treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 66:S820","journal-title":"Arthritis Rheumatol"},{"key":"3475_CR97","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","volume":"48","author":"TM Woodruff","year":"2011","unstructured":"Woodruff TM, Nandakumar KS, Tedesco F (2011) Inhibiting the C5\u2013C5a receptor axis. Mol Immunol 48:1631\u20131642","journal-title":"Mol Immunol"},{"key":"3475_CR98","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","volume":"350","author":"P Hillmen","year":"2004","unstructured":"Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, Rother RP (2004) Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 350:552\u2013559","journal-title":"N Engl J Med"},{"key":"3475_CR99","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355:1233\u20131243","journal-title":"N Engl J Med"},{"key":"3475_CR100","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nurnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169\u20132181","journal-title":"N Engl J Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3475-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3475-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3475-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3475-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:53:45Z","timestamp":1749574425000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3475-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3475"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3475-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]}}}